| Early prediction of mortality risk among patients with severe COVID-19, using machine learning C Hu, Z Liu, Y Jiang, O Shi, X Zhang, K Xu, C Suo, Q Wang, Y Song, K Yu, ... International journal of epidemiology 49 (6), 1918-1929, 2020 | 153 | 2020 |
| Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017 Z Liu, C Suo, X Mao, Y Jiang, L Jin, T Zhang, X Chen Cancer 126 (10), 2267-2278, 2020 | 112 | 2020 |
| Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017 J Fan, Z Liu, X Mao, X Tong, T Zhang, C Suo, X Chen Cancer medicine 9 (18), 6875-6887, 2020 | 96 | 2020 |
| Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study Z Liu, K Xu, Y Jiang, N Cai, J Fan, X Mao, C Suo, L Jin, T Zhang, X Chen International Journal of Epidemiology 50 (1), 128-142, 2021 | 71 | 2021 |
| Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China Z Liu, X Mao, Y Jiang, N Cai, L Jin, T Zhang, X Chen Cancer medicine 8 (12), 5787-5799, 2019 | 46 | 2019 |
| Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta‐analysis X Mao, KS Cheung, C Peng, LY Mak, HM Cheng, J Fung, N Peleg, ... Hepatology 77 (5), 1735-1745, 2023 | 44 | 2023 |
| COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis KS Cheung, CH Mok, X Mao, R Zhang, IFN Hung, WK Seto, MF Yuen Clinical and Molecular Hepatology 28 (4), 890, 2022 | 37 | 2022 |
| Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes LY Mak, RWH Hui, CH Lee, XH Mao, KS Cheung, DKH Wong, DTW Lui, ... Hepatology 77 (2), 606-618, 2023 | 26 | 2023 |
| Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people Z Liu, C Lin, X Mao, C Guo, C Suo, D Zhu, W Jiang, Y Li, J Fan, C Song, ... Gut 72 (12), 2354-2363, 2023 | 24 | 2023 |
| World-wide prevalence of substitutions in HCV genome associated with resistance to direct-acting antiviral agents Z Liu, X Mao, J Wu, K Yu, Q Yang, C Suo, M Lu, L Jin, T Zhang, X Chen Clinical Gastroenterology and Hepatology 19 (9), 1906-1914. e25, 2021 | 15 | 2021 |
| Non‐invasive fibrosis markers are associated with mortality risk in both general populations and non‐alcoholic fatty liver disease patients X Mao, Z Liu, O Shi, K Yu, Y Jiang, L Jin, T Zhang, X Chen Hepatology Research 51 (1), 90-101, 2021 | 15 | 2021 |
| Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients KS Cheung, LK Lam, RWH Hui, X Mao, RR Zhang, KH Chan, IFN Hung, ... Clinical and Molecular Hepatology 28 (3), 553, 2022 | 14 | 2022 |
| Global burden of nonalcoholic fatty liver disease, 1990 to 2019: Findings from the global burden of disease study 2019 W Jiang, X Mao, Z Liu, T Zhang, L Jin, X Chen Journal of Clinical Gastroenterology 57 (6), 631-639, 2023 | 13 | 2023 |
| Prevalence of HCV resistance‐associated substitutions among treatment‐failure patients receiving direct‐acting antiviral agents Z Liu, X Mao, K Yu, C Suo, L Jin, T Zhang, X Chen Journal of Viral Hepatitis 27 (6), 585-592, 2020 | 12 | 2020 |
| Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos (t … LY Mak, D Wong, A Kuchta, M Hilfiker, A Hamilton, N Chow, XH Mao, ... Clinical and Molecular Hepatology 29 (1), 146, 2023 | 11 | 2023 |
| Global burden of liver cancer and cirrhosis among children, adolescents, and young adults Z Liu, X Mao, L Jin, T Zhang, X Chen Digestive and Liver Disease 52 (2), 240-243, 2020 | 8 | 2020 |
| HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos (t) ide analogue in CHB LY Mak, D Wong, A Kuchta, M Hilfiker, A Hamilton, N Chow, X MAO, ... Clin Mol Hepatol, 2022 | 6 | 2022 |
| Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients KS Cheung, LK Lam, X Mao, JT Tan, PH Ooi, R Zhang, KH Chan, ... Vaccines 11 (3), 497, 2023 | 3 | 2023 |
| Changing trend in reported hepatitis B incidence among residents of Mainland China, 2004–2017 W JIANG, X MAO, Z LIU Chinese Journal of Public Health 38 (3), 257-261, 2022 | 3 | 2022 |
| “Fatty” or “steatotic”: position statement from a linguistic perspective by the Chinese-speaking community L Miao, SM Ye, MH Zheng, JG Fan, WK Seto, HH Yu, ML Yu, JH Kao, ... Journal of Hepatology, 2024 | 1 | 2024 |
